251 related articles for article (PubMed ID: 35856557)
1. Panoramic comparison between NK cells in healthy and cancerous liver through single-cell RNA sequencing.
Liu H; Zhao R; Qin R; Sun H; Huang Q; Liu L; Tian Z; Nashan B; Sun C; Sun R
Cancer Biol Med; 2022 Jul; 19(9):1334-51. PubMed ID: 35856557
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin-like transcript 2 as an impaired anti-tumor cytotoxicity marker of natural killer cells in patients with hepatocellular carcinoma.
Sakata T; Yoshio S; Yamazoe T; Mori T; Kakazu E; Aoki Y; Aoyanagi N; Okamoto T; Ito T; Toyoda H; Kawaguchi T; Ono Y; Takahashi Y; Taketomi A; Kanto T
Front Immunol; 2024; 15():1389411. PubMed ID: 38638429
[TBL] [Abstract][Full Text] [Related]
3. The miR-561-5p/CX
Chen EB; Zhou ZJ; Xiao K; Zhu GQ; Yang Y; Wang B; Zhou SL; Chen Q; Yin D; Wang Z; Shi YH; Gao DM; Chen J; Zhao Y; Wu WZ; Fan J; Zhou J; Dai Z
Theranostics; 2019; 9(16):4779-4794. PubMed ID: 31367257
[TBL] [Abstract][Full Text] [Related]
4. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma.
Zhang PF; Gao C; Huang XY; Lu JC; Guo XJ; Shi GM; Cai JB; Ke AW
Mol Cancer; 2020 Jun; 19(1):110. PubMed ID: 32593303
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic Characterization by Single-Cell Mass Cytometry of Human Intrahepatic and Peripheral NK Cells in Patients with Hepatocellular Carcinoma.
Yoshida Y; Yoshio S; Yamazoe T; Mori T; Tsustui Y; Kawai H; Yoshikawa S; Fukuhara T; Okamoto T; Ono Y; Takahashi Y; Hashida R; Kawaguchi T; Taketomi A; Kanto T
Cells; 2021 Jun; 10(6):. PubMed ID: 34198593
[TBL] [Abstract][Full Text] [Related]
6. Diminished absolute counts of CD56dim and CD56bright natural killer cells in peripheral blood from Egyptian patients with hepatocellular carcinoma.
Fathy A; Eldin MM; Metwally L; Eida M; Abdel-Rehim M
Egypt J Immunol; 2009; 16(2):17-25. PubMed ID: 22059350
[TBL] [Abstract][Full Text] [Related]
7. Combined analysis of bulk and single-cell RNA sequencing reveals novel natural killer cell-related prognostic biomarkers for predicting immunotherapeutic response in hepatocellular carcinoma.
Zhang K; Yuan E
Front Immunol; 2023; 14():1142126. PubMed ID: 37056756
[TBL] [Abstract][Full Text] [Related]
8. Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cells.
Hu J; Wang E; Liu L; Wang Q; Xia D; Bai W; Tie J; Li X; Yuan J; Yang S; Jiang D; Shi J; Sun Y; Wang J; Zhang C; Niu J; Li K; He C; Guo W; Lv Y; Chen H; Yuan X; Yu T; Wang Z; Luo B; Han N; Zhu Y; Yin Z; Fan D; Zhang Z; Yang K; Han G
Invest New Drugs; 2020 Oct; 38(5):1247-1256. PubMed ID: 31832851
[TBL] [Abstract][Full Text] [Related]
9. Single-cell data revealed exhaustion of characteristic NK cell subpopulations and T cell subpopulations in hepatocellular carcinoma.
Cui Z; Li H; Liu C; Wang J; Chen C; Hu S; Zhao X; Li G
Aging (Albany NY); 2024 Apr; 16(7):6550-6565. PubMed ID: 38604154
[TBL] [Abstract][Full Text] [Related]
10. Tim-3 Hampers Tumor Surveillance of Liver-Resident and Conventional NK Cells by Disrupting PI3K Signaling.
Tan S; Xu Y; Wang Z; Wang T; Du X; Song X; Guo X; Peng J; Zhang J; Liang Y; Lu J; Peng J; Gao C; Wu Z; Li C; Li N; Gao L; Liang X; Ma C
Cancer Res; 2020 Mar; 80(5):1130-1142. PubMed ID: 31848194
[TBL] [Abstract][Full Text] [Related]
11. Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases.
Hou JY; Wu HY; He RQ; Lin P; Dang YW; Chen G
Pathol Res Pract; 2019 Jan; 215(1):177-194. PubMed ID: 30473171
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive characterization of tumor infiltrating natural killer cells and clinical significance in hepatocellular carcinoma based on gene expression profiles.
Wu M; Mei F; Liu W; Jiang J
Biomed Pharmacother; 2020 Jan; 121():109637. PubMed ID: 31810126
[TBL] [Abstract][Full Text] [Related]
13. Deciphering the immune heterogeneity dominated by natural killer cells with prognostic and therapeutic implications in hepatocellular carcinoma.
Guo C; Tang Y; Li Q; Yang Z; Guo Y; Chen C; Zhang Y
Comput Biol Med; 2023 May; 158():106872. PubMed ID: 37030269
[TBL] [Abstract][Full Text] [Related]
14. CD56
Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
Front Immunol; 2019; 10():14. PubMed ID: 30761123
[TBL] [Abstract][Full Text] [Related]
15. Restoring NK cells functionality via cytokine activation enhances cetuximab-mediated NK-cell ADCC: A promising therapeutic tool for HCC patients.
Mahgoub S; Abosalem H; Emara M; Kotb N; Maged A; Soror S
Mol Immunol; 2021 Sep; 137():221-227. PubMed ID: 34284214
[TBL] [Abstract][Full Text] [Related]
16. Mining featured biomarkers associated with vascular invasion in HCC by bioinformatics analysis with TCGA RNA sequencing data.
Zhang R; Ye J; Huang H; Du X
Biomed Pharmacother; 2019 Oct; 118():109274. PubMed ID: 31545220
[TBL] [Abstract][Full Text] [Related]
17. Liver-infiltrating CD11b
Zhang QF; Yin WW; Xia Y; Yi YY; He QF; Wang X; Ren H; Zhang DZ
Cell Mol Immunol; 2017 Oct; 14(10):819-829. PubMed ID: 27321064
[TBL] [Abstract][Full Text] [Related]
18. New miRNA Signature Heralds Human NK Cell Subsets at Different Maturation Steps: Involvement of miR-146a-5p in the Regulation of KIR Expression.
Pesce S; Squillario M; Greppi M; Loiacono F; Moretta L; Moretta A; Sivori S; Castagnola P; Barla A; Candiani S; Marcenaro E
Front Immunol; 2018; 9():2360. PubMed ID: 30374356
[TBL] [Abstract][Full Text] [Related]
19. MiR-506 Promotes Natural Killer Cell Cytotoxicity against Human Hepatocellular Carcinoma Cells by Targeting STAT3.
Su Z; Ye X; Shang L
Yonsei Med J; 2019 Jan; 60(1):22-29. PubMed ID: 30554487
[TBL] [Abstract][Full Text] [Related]
20. Human liver single nucleus and single cell RNA sequencing identify a hepatocellular carcinoma-associated cell-type affecting survival.
Alvarez M; Benhammou JN; Darci-Maher N; French SW; Han SB; Sinsheimer JS; Agopian VG; Pisegna JR; Pajukanta P
Genome Med; 2022 May; 14(1):50. PubMed ID: 35581624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
